| http://www.w3.org/ns/prov#value | - thods, e.g., treating the bacterial isolate with binary ethyleneimine (BEI) as described in U.S. Pat. No. 5,565,205, or inactivation with formalin, glutaraldehyde, heat, irradiation, BPL, or other inactivating agents known to the art. [0048] In addition to inactivated viral isolates, a vaccine product can also include an appropriate amount of one or more commonly used adjuvants.
|
